Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2f5c494c7664892b6f9c759b0e9e3f55 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 |
filingDate |
2001-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2002-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-0203918-A2 |
titleOfInvention |
Treating neural conditions resulting from spinal cord contusions and other causes |
abstract |
β2-agonists, such as clenbuterol and salbutamol can enhance the recovery of locomotive function and/or neuromuscular strength following spinal cord injuries or as a result of degenerative neural conditions such as Mnd. Pharmacological compositions for treating spinal cord injuries and degenerative neural conditions are also provided. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006082046-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1754474-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008528536-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2007206-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2007206-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03020257-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2821072-A1 |
priorityDate |
2000-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |